KLF2 and atherosclerosis: Previous studies showed that KLF2-transduced ECs could exert anti-inflammatory effect and mediate monocyte/macrophage (Mo/Mø) polarization in atherosclerosis 13, indicating that KLF2-modified ECs could be used for the treatment of inflammatory diseases.